2026 Q1 Portfolio Activity
In 2026 Q1, Foresite Capital Management V, LLC maintained a portfolio of 10 distinct positions. The most significant new addition was Eikon Therapeutics, Inc., now representing 5.15% of the total fund value. They heavily accumulated shares in Hims & Hers Health, Inc., increasing the position by 170.2%. Conversely, Foresite Capital Management V, LLC completely exited their position in Natera, Inc..
Position History
hover any row below to update
Loading…
Total Positions
10
Quarter
2026 Q1
Top Holding
ALMS (47.9%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-10 of 10
Foresite Capital Management V, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALMS
ALUMIS INC.
|
Healthcare | 47.94% | 34.31% |
#1
Prev: #1
|
6.5 |
—
|
117,647 | 2.0% |
P
S
|
5,896,995 | $129,910,800 |
$13.29
+65.6%
|
2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
CGON
CG Oncology, In...
|
Healthcare | 25.08% | 25.36% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
1,004,050 | $67,954,104 |
$38.10
+62.5%
|
2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
IRON
Disc Medicine, ...
|
Healthcare | 8.83% | 14.45% |
#3
Prev: #3
|
7.0 |
—
|
75,000 | 25.1% |
P
S
|
374,069 | $23,917,972 |
$32.46
+109.5%
|
2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
HIMS
Hims & Hers Hea...
|
Healthcare | 5.65% | 5.39% |
#4
2
Prev: #6
|
5.8 |
—
|
465,000 | 170.2% |
P
S
|
738,151 | $15,324,015 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
Eikon Therapeut...
|
|
Unknown | 5.15% | — |
#5
Prev: #—
|
6.1 |
—
|
1,318,983 | — |
NEW
|
1,318,983 | $13,954,840 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
LYEL
Lyell Immunopha...
|
Healthcare | 3.53% | 8.93% |
#6
1
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
477,078 | $9,570,185 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
Pharvaris N.V.
|
Healthcare | 2.02% | — |
#7
Prev: #—
|
4.3 |
—
|
194,125 | — |
NEW
|
194,125 | $5,484,031 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NRIX
Nurix Therapeut...
|
Healthcare | 1.52% | — |
#8
Prev: #—
|
4.1 |
—
|
265,000 | — |
NEW
|
265,000 | $4,107,500 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MAZE
Maze Therapeuti...
|
Healthcare | 0.29% | 2.17% |
#9
2
Prev: #7
|
0.1 |
—
|
-60,386 | -70.0% |
P
S
|
25,905 | $773,264 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
Natera, Inc.
|
Healthcare | 0.00% | 9.39% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-67,356 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-10 of 10 holdings